Charpentier’s little team discovered that the CRISPR-Cas9 system accomplished its viral-defense mission using only three components: tracrRNA, crRNA, and the Cas9 enzyme. The tracrRNA took long strands of RNA and processed them into the small crRNAs that were targeted at specific sequences in an attacking virus.
